Location History:
- Pasadena, CA (US) (1989)
- Pomona, CA (US) (1993)
- El Monte, CA (US) (2000)
- So. El Monte, CA (US) (2002 - 2003)
- South El Monte, CA (US) (2002 - 2004)
- Diamond Bar, CA (US) (2013 - 2015)
- Rancho Cucamonga, CA (US) (2002 - 2022)
Company Filing History:
9 out of 22 
1 out of 1 
7 out of 832,812 Years Active: 1989-2022
Title: Innovations in Inhalable Insulin: The Contributions of Mary Ziping Luo
Introduction: Mary Ziping Luo, an accomplished inventor based in Rancho Cucamonga, California, has made significant strides in the field of pharmaceutical innovations. With an impressive portfolio of 17 patents, her work primarily focuses on the development of high-purity inhalable insulin products, pushing the boundaries of diabetes treatment.
Latest Patents: Among her latest contributions is a groundbreaking patent for high-purity inhalable particles of insulin and insulin analogues. This innovation introduces a pulmonary pharmaceutical product characterized by insulin particles with a micrometer-level size. The composition boasts remarkable attributes, such as a minimum purity of 96% on a dried basis, a low total amount of insulin-related impurities not exceeding 2%, and minimal solvent and non-solvent impurities. Notably, up to 99% by volume of the insulin particles are less than 5 micrometers, ensuring effective delivery to the lungs. Furthermore, the high-efficiency method for producing this inhalable insulin achieves a yield rate of 75% to 85% or more, representing a significant advancement in pharmaceutical manufacturing.
Career Highlights: Throughout her career, Mary Ziping Luo has worked with notable companies in the pharmaceutical industry, including Amphastar Pharmaceuticals, Inc. Her contributions in these roles have led to innovations that enhance the quality and efficiency of diabetic treatments.
Collaborations: Mary has collaborated with respected professionals in her field, including Jack Yongfeng Zhang and Frank Zhishi Xia. Their partnerships have facilitated groundbreaking research and development efforts, further establishing her as a leader in pharmaceutical innovations.
Conclusion: Mary Ziping Luo's commitment to enhancing diabetic treatment through high-purity inhalable insulin represents a significant milestone in pharmaceutical science. Her extensive patent portfolio and collaboration with industry experts illustrate her influential role as an inventor and innovator, paving the way for more effective medical solutions.